CROCETTI, LETIZIA
 Distribuzione geografica
Continente #
EU - Europa 3.150
NA - Nord America 2.964
AS - Asia 468
AF - Africa 15
SA - Sud America 5
Totale 6.602
Nazione #
US - Stati Uniti d'America 2.961
PL - Polonia 1.632
RU - Federazione Russa 732
IT - Italia 250
IE - Irlanda 195
SE - Svezia 185
SG - Singapore 154
HK - Hong Kong 122
CN - Cina 88
GB - Regno Unito 48
IN - India 41
FI - Finlandia 33
VN - Vietnam 30
DE - Germania 27
BE - Belgio 21
JO - Giordania 20
CI - Costa d'Avorio 13
ES - Italia 11
TR - Turchia 7
BR - Brasile 5
NL - Olanda 5
UA - Ucraina 5
FR - Francia 4
CA - Canada 3
EG - Egitto 2
IR - Iran 2
BY - Bielorussia 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
RO - Romania 1
TW - Taiwan 1
Totale 6.602
Città #
Warsaw 1.631
Santa Clara 765
Fairfield 323
Dublin 194
Chandler 193
Ashburn 165
Seattle 157
Woodbridge 138
Singapore 123
Cambridge 118
Ann Arbor 116
Houston 111
Florence 108
Wilmington 106
Hong Kong 81
Altamura 78
Lawrence 77
Princeton 52
Buffalo 45
Moscow 42
Mumbai 33
Beijing 28
Boston 26
Shanghai 26
Medford 25
Dong Ket 22
Boardman 20
Brussels 20
San Diego 19
London 14
Abidjan 13
Barcelona 11
Jacksonville 11
New York 10
West Jordan 10
Kent 9
Los Angeles 9
Yubileyny 9
Hillsboro 8
Norwalk 7
Phoenix 7
Falls Church 6
Gavirate 6
Helsinki 6
Izmir 6
Lappeenranta 6
Menlo Park 5
Pune 5
Shenzhen 5
Teresópolis 5
Misano Adriatico 4
Andover 3
Chennai 3
Esslingen am Neckar 3
Napoli 3
Scandicci 3
Zhengzhou 3
Carol Stream 2
Castelliri 2
Crawley 2
Milan 2
Munich 2
Paris 2
Perugia 2
Prescot 2
Redmond 2
Redwood City 2
Rome 2
Rui'an 2
Southwark 2
Tappahannock 2
Toronto 2
Trumbull 2
Amsterdam 1
Antwerpen 1
Atlanta 1
Bologna 1
Cairo 1
Campi Bisenzio 1
Cedar Knolls 1
Chicago 1
Chieti 1
Clifton 1
Dallas 1
Dalmine 1
Ergolding 1
Foligno 1
Fuzhou 1
Garden City 1
Guangzhou 1
Hounslow 1
Impruneta 1
Istanbul 1
Jinhua 1
Laurel 1
Leawood 1
Minsk 1
Montecatini Terme 1
North Babylon 1
Ottawa 1
Totale 5.091
Nome #
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 277
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 243
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 233
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 228
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 226
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 224
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 219
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 215
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 212
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 195
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 193
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 190
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 173
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 164
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 159
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 154
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 149
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 143
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 139
Cinnoline derivatives as human neutrophil elastase inhibitors 136
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 136
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 128
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 120
A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases. 119
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 119
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 116
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 105
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 100
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 93
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 91
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 91
A patenting perspective on human neutrophil elastase (HNE) inhibitors (2014-2018) and their therapeutic applications 86
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 85
GABAA receptor subtype modulators in medicinal chemistry: an updated patent review (2014-present) 83
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 80
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 79
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 78
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 78
New insights on the arylpiperazinylalkyl pyridazinone ET1 as potent antinociceptive and anti-inflammatory agent 72
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 70
Design and synthesis of the first indole-based blockers of Panx-1 channel 66
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 62
Editorial: Serine protease inhibitors and their therapeutic applications 61
New Panx-1 Blockers: Synthesis, Biological Evaluation and Molecular Dynamic Studies 60
Design, Synthesis and Pharmacological Evaluation of New Quinoline-Based Panx-1 Channel Blockers 59
Repurposing strategies on pyridazinone-based series by pharmacophore- and structure-driven screening 57
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 50
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 50
Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity 49
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 49
X-ray structural study of human neutrophil elastase inhibition with a series of azaindoles, azaindazoles and isoxazolones 45
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 44
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 41
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 39
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 38
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 37
Pyridazin-3(2H)-one as New FABP4 Inhibitors Suggested by Molecular Growing Experiments 36
Anti-Inflammatory Activity of Pyrazolo[1,5-a]quinazolines 34
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 34
PDE4 Inhibitors: Profiling Hits through the Multitude of Structural Classes 28
Steered Molecular Dynamics Simulations Study on FABP4 Inhibitors 26
3,8-Disubstituted Pyrazolo[1,5-a]quinazoline as GABAA Receptor Modulators: Synthesis, Electrophysiological Assays, and Molecular Modelling Studies 17
Totale 6.783
Categoria #
all - tutte 19.130
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.130


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020656 0 0 0 0 119 92 91 108 83 71 75 17
2020/2021866 62 71 20 103 45 87 67 52 119 149 38 53
2021/2022411 14 14 35 12 18 29 12 35 20 33 100 89
2022/2023986 96 233 47 71 54 170 126 56 85 5 31 12
2023/2024389 11 41 64 12 22 40 15 106 11 36 22 9
2024/20251.890 110 287 161 422 910 0 0 0 0 0 0 0
Totale 6.783